Tumor-LN-oC reaches Month 6 of the project

On the 18th and 19th of November, the Tumor-LN-oC consortium met for the M6 meeting in Athens. The meeting closed the first half year of project implementation and served to plan for the months ahead.

Within Tumor-LN-oC (Tumor and Lymph Node on Chip for cancer studies), the consortium is developing a tumor-lymph node-on-chip platform which will connect primary surgically removed tumor and lymph node tissues from the same lung cancer patient. The platform will thus serve as a “biological twin” of the patient, making it possible to study the interaction of primary tumors with LNs for individual patients and thereby monitor the LN metastasis process. This information could lead to novel diagnostic tools and therapeutic approaches for lung cancer. More information is available HERE.

We´re looking forward to the next 6 months of the project realization and future achievements!